Maker of Trump’s Unproven Virus Cure Boosting Capacity 10 Times

The world’s largest maker of an anti-malarial drug that U.S. President Donald Trump has touted as a “game changer” in the treatment of the deadly coronavirus plans to boost capacity more than ten-fold to meet surging global demand.

Cadila Healthcare Ltd. will increase production of hydroxychloroquine sulphate to as much as 35 tons, or about 200 million individual doses per month, from about 3 tons per month currently, according to Sharvil Patel, the Ahmedabad-based company’s managing director.

“We are scaling up,” Patel said in a telephone interview Tuesday. “We could do more, but currently this is our planning.”

Though ...